[Skip to Content]
[Skip to Content Landing]
Article
May 27, 1996

Prevalence of Undiagnosed Pernicious Anemia in the Elderly

Arch Intern Med. 1996;156(10):1097-1100. doi:10.1001/archinte.1996.00040041097008
Abstract

Background:  Existing information about the prevalence of pernicious anemia is largely based on older surveys that favored florid manifestations, tended to be retrospective analyses of previously diagnosed disease, and usually studied homogeneous European populations. The lack of current data in the United States has, among other things, hampered discussions of the proposal to increase folate intake by the general population.

Objective:  To estimate the prevalence of undiagnosed and untreated pernicious anemia among the elderly.

Methods:  A prospective survey of cobalamin levels and anti—intrinsic factor antibody was done in the elderly. Blood testing was done in 729 people aged 60 years or older and follow-up assessment with the Schilling test and other tests was offered when results were abnormal.

Results:  Seventeen subjects were found to have pernicious anemia, usually with only minimal clinical manifestations of cobalamin deficiency. Although cobalamin deficiency had been suspected by the physicians of three subjects, they had been treated inadequately and still had evidence of deficiency. Excluding these three partially treated subjects from the analysis, 1.9% of the survey population had unrecognized and untreated pernicious anemia. The prevalence was 2.7% in women and 1.4% in men; 4.3% of the black women and 4.0% of the white women had pernicious anemia.

Conclusions:  Undiagnosed pernicious anemia is a common finding in the elderly, especially among black and white women. If these findings can be extrapolated, almost 800000 elderly people in the United States have undiagnosed and untreated pernicious anemia, and, thus, would be at possible risk for masked cobalamin deficiency if exposed to large amounts of folate. This number does not include those elderly with cobalamin deficiency caused by other disorders or the still unknown number of younger people with unrecognized pernicious anemia and other causes of deficiency.(Arch Intern Med. 1996;156:1097-1100)

References
1.
Chanarin I. Megaloblastic Anaemias . 2nd ed. Boston, Mass: Blackwell Scientific Publications Inc; 1979.
2.
 Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects . MMWR Morbid Mortal Wkly Rep. 1992;41(RR-14):1-7.
3.
Willett WC.  Folic acid and neural tube defect: can't we come to closure? Am J Public Health. 1992;82:666-668.Article
4.
Rosenberg IH.  Folic acid and neural-tube defects: time for action? N Engl J Med. 1992;327:1875-1877.Article
5.
Wald N.  Folic acid and the prevention of neural tube defects . Ann N Y Acad Sci. 1993;678:112-129.Article
6.
Mills JL, Raymond E.  Effects of recent research on recommendations for periconceptional folate supplement use . Ann N Y Acad Sci. 1993;678:137-145.Article
7.
Rush D.  Periconceptional folate and neural tube defect . Am J Clin Nutr. 1994; 59(suppl):511S-516S.
8.
Carmel R, Karnaze DS, Weiner JM.  Neurological abnormalities in cobalamin deficiency are associated with higher cobalamin 'analogue' values than are hematological abnormalities . J Lab Clin Med. 1988;111:57-62.
9.
Nimo RE, Carmel R.  Increased sensitivity of detection of the blocking (type I) anti-intrinsic factor antibody . Am J Clin Pathol. 1987;88:729-733.
10.
Roitt IM, Doniach D, Shapland C.  Autoimmunity in pernicious anemia and atrophic gastritis . Ann N Y Acad Sci. 1965;124:644-656.Article
11.
Rothenberg SP, Kantha KRK, Ficarra A.  Autoantibodies to intrinsic factor: their determination and clinical usefulness . J Lab Clin Med. 1971;77:476-484.
12.
Carmel R.  Reassessment of the relative prevalences of antibodies to gastric parietal cell and to intrinsic factor in patients with pernicious anaemia: influence of patient age and race . Clin Exp Immmunol. 1992;89:74-77.Article
13.
Carmel R.  Pepsinogens and other serum markers in pernicious anemia . Am J Clin Pathol. 1988;90:442-446.
14.
Walsh JH, Grossman Ml. Gastrin. N Engl J Med. 1975;292:1377-1384.Article
15.
Carmel R, Gott PS, Waters CH, et al.  The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities . Eur J Haematol. 1995;54:245-253.Article
16.
Carmel R, Johnson CS, Weiner JM.  Pernicious anemia in Latin Americans is not a disease of the elderly . Arch Intern Med. 1987;147:1995-1996.Article
17.
National Center for Health Statistics.  Advanced report of final natality statistics . Monthly Vital Statistics Report . 1990;44(No. 9): Suppl.
18.
United States Population Estimates by Age, Sex, Race and Origin, 1990-1994 . Washington, DC: US Bureau of the Census; Population Division Release PPL-21.
19.
Carmel R, Johnson CS.  Racial patterns in pernicious anemia: early age of onset and increased frequency of intrinsic factor antibody in black women . N Engl J Med. 1978;298:647-650.Article
20.
Carmel R.  Macrocytosis, mild anemia, and delay in diagnosis of pernicious anemia . Arch Intern Med. 1979;139:47-50.Article
21.
Shojania AM.  Physicians' management of suspected vitamin B12 deficiency . Can Med Assoc J. 1980;123:1127-1130.
22.
Carmel R, Karnaze DS.  Physician response to low serum cobalamin levels . Arch Intern Med. 1986;146:1161-1165.Article
×